Investigations
R1 RCM Inc.
Overview
Overview
- Deadline:
- Upcoming
| Company Name: | Company Name: R1 RCM Inc. |
| Stock Symbol: | Stock Symbol: RCM |
BFA is investigating whether New Mountain Capital’s $13.25 per share non-binding offer to acquire R1 RCM Inc. (NYSE: RCM) is fair to minority shareholders. Minority shareholders may have no voice in the transaction because New Mountain Capital does not intend to subject the potential merger transaction to a minority shareholder vote.
If you own shares of R1 RCM, you are encouraged to submit your information.
Investigation Details:
R1 RCM is controlled by funds affiliated with New Mountain Capital and TowerBrook through their collective ownership of Company stock representing 68% of the total voting power.
On July 2, 2024, New Mountain Capital’s investment funds presented an acquisition proposal to the special committee of the board of directors of R1 RCM. The non-binding proposal seeks to acquire all the shares New Mountain Capital does not own for $13.25 per share, while inviting TowerBrook to rollover all or a portion of its stock into the post-close company. Should the special committee accept the proposal, minority shareholders will be cashed out and deprived of any future upside in the private company.
BFA believes New Mountain Capital’s acquisition proposal may result in minority stockholders receiving an unfair price for their R1 RCM shares. As potential owners of the post-close company, New Mountain Capital and TowerBrook have an incentive to pay as little as possible to acquire the Company, which may explain why the $13.25 per share acquisition proposal is far lower than analyst price targets, which are as high as $20.
BFA is concerned that New Mountain Capital and TowerBrook, as well as members of R1 RCM’s board of directors, may breach their fiduciary duties should they approve an unfair merger transaction for the benefit of New Mountain Capital and TowerBrook.
Next Steps:
If you currently own shares of R1 RCM, you may have legal options and you are encouraged to submit your information to speak with an attorney.
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Contact:
Ross Shikowitz
ross@bfalaw.com
212-789-2303
Fill out the form for more information.
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
If you own shares of R1 RCM, you are encouraged to submit your information.
Investigation Details:
R1 RCM is controlled by funds affiliated with New Mountain Capital and TowerBrook through their collective ownership of Company stock representing 68% of the total voting power.
On July 2, 2024, New Mountain Capital’s investment funds presented an acquisition proposal to the special committee of the board of directors of R1 RCM. The non-binding proposal seeks to acquire all the shares New Mountain Capital does not own for $13.25 per share, while inviting TowerBrook to rollover all or a portion of its stock into the post-close company. Should the special committee accept the proposal, minority shareholders will be cashed out and deprived of any future upside in the private company.
BFA believes New Mountain Capital’s acquisition proposal may result in minority stockholders receiving an unfair price for their R1 RCM shares. As potential owners of the post-close company, New Mountain Capital and TowerBrook have an incentive to pay as little as possible to acquire the Company, which may explain why the $13.25 per share acquisition proposal is far lower than analyst price targets, which are as high as $20.
BFA is concerned that New Mountain Capital and TowerBrook, as well as members of R1 RCM’s board of directors, may breach their fiduciary duties should they approve an unfair merger transaction for the benefit of New Mountain Capital and TowerBrook.
Next Steps:
If you currently own shares of R1 RCM, you may have legal options and you are encouraged to submit your information to speak with an attorney.
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Contact:
Ross Shikowitz
ross@bfalaw.com
212-789-2303
Fill out the form for more information.
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.